Urbil en es it fr

Urbil Brand names, Urbil Analogs

Urbil Brand Names Mixture

  • No information avaliable

Urbil Chemical_Formula


Urbil RX_link

No information avaliable

Urbil fda sheet

Urbil msds (material safety sheet)

Urbil Synthesis Reference

No information avaliable

Urbil Molecular Weight

309.469 g/mol

Urbil Melting Point

< 25 oC

Urbil H2O Solubility

Soluble as HCl salt

Urbil State


Urbil LogP


Urbil Dosage Forms

Tablets (oral, 1 mg)

Urbil Indication

Used for the symptomatic treatment of parkinsonism.

Urbil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Urbil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Urbil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Urbil Patient Information

Urbil Organisms Affected

Humans and other mammals